Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28973554 | 1.00 | LMNA (0.44) | LMNATYREPHX1SMN1; SMN2RIPK1 | |
| SCHEMBL477443 | 1.00 | LMNA (0.44) | LMNATYREPHX1SMN1; SMN2RIPK1 | |
| SCHEMBL26326672 | 0.94 | CA12 (0.50) | EPHX1CA12CA1CA2CA9 | |
| SCHEMBL10708786 | 0.91 | LMNA (0.52) | LMNATYRTDP1 | |
| SCHEMBL3586191 | 0.91 | LMNA (0.52) | LMNATYRTDP1 | |
| SCHEMBL11642416 | 0.90 | CA12 (0.46) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7110307 | 0.83 | CYP3A4 (0.45) | LMNASMN1; SMN2RIPK1L3MBTL1BCHE | |
| SCHEMBL16487204 | 0.82 | SLC6A2 (0.44) | LMNATYREPHX1L3MBTL1MAPT | |
| SCHEMBL18623182 | 0.81 | CA1 (0.51) | LMNATYREPHX1MAPTTDP1 | |
| SCHEMBL8671295 | 0.81 | SMN1; SMN2 (0.58) | LMNASMN1; SMN2L3MBTL1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903476-A | Large-steric-hindrance polybasic aniline/phenol and preparation method thereof | 青岛科技大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-114014869-B | Chiral 2,2' -bipyridine ligand and preparation method and application thereof | 西安交通大学 | 2023-03-24 | — | — | CN | disclosed |
| US-8563786-B2 | Method for producing optically active alcohol | MITSUI CHEMICALS, INC. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-8329855-B2 | Thienocoronene-imide semiconducting compounds and polymers | POLYERA CORPORATION (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120264900-A1 | THIENOCORONENE-IMIDE SEMICONDUCTING COMPOUNDS AND POLYMERS | USINVEST LLC | 2012-10-18 | — | — | US | disclosed |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-12 | — | — | US | disclosed |
| EP-2412694-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | Mitsui Chemicals, Inc. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20110226338-A1 | PYRROLO[3,2-B]PYRROLE SEMICONDUCTING COMPOUNDS AND DEVICES INCORPORATING SAME | RAYNERGY TEK INC. (TW) | 2011-09-22 | — | — | US | disclosed |
| US-20110213117-A1 | Organic Semiconducting Polymers | POLYERA CORPORATION (US) | 2011-09-01 | — | — | US | disclosed |
| US-20110120558-A1 | SEMICONDUCTOR MATERIALS PREPARED FROM RYLENE-(PI-ACCEPTOR)COPOLYMERS | BASF SE | 2011-05-26 | — | — | US | disclosed |
| US-20110079773-A1 | Selectively Functionalized Rylene Imides and Diimides | NORTHWESTERN UNIVERSITY | 2011-04-07 | — | — | US | disclosed |
| EP-1562901-B1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |
| US-7476681-B2 | anticarcinogenic agent; prostate cancer, benign prostatic hyperplasia, prostatic intraepithelial neoplasia, hirsutism, acne, androgenic alopecia, or polycystic ovary syndrome, prostate, lung, pancreatic, colon, renal cancer, myeloid leukemia | SCHERING CORPORATION (US) | 2009-01-13 | — | — | US | disclosed |
| US-7476681-B2 | anticarcinogenic agent; prostate cancer, benign prostatic hyperplasia, prostatic intraepithelial neoplasia, hirsutism, acne, androgenic alopecia, or polycystic ovary syndrome, prostate, lung, pancreatic, colon, renal cancer, myeloid leukemia | SCHERING CORPORATION (US) | 2009-01-13 | — | — | US | disclosed |
| US-6166072-A | Amino acid derivatives | ALLELIX NEUROSCIENCE, INC. (CA) | 2000-12-26 | — | — | US | disclosed |
| WO-1999034790-A1 | GLYCINE TRANSPORT INHIBITORS | ALLELIX NEUROSCIENCE, INC. (US) | 1999-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110079773-A1 | Selectively Functionalized Rylene Imides and Diimides | RAE1, RICTOR, RET | LMNA 4484/4885TYR 216/4885EPHX1 3814/4885 |
| US-20120264900-A1 | THIENOCORONENE-IMIDE SEMICONDUCTING COMPOUNDS AND POLYMERS | TST, TPR, SLC19A2 | LMNA 4411/4885TYR 208/4885EPHX1 2093/4885 |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, FHIT | LMNA 1422/4885TYR 144/4885EPHX1 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.